A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2
Clinical trial NCT05911087 · UNKNOWN
Trial details
- NCT number
- NCT05911087
- Sponsor
- Stemirna Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2023-07-31
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.